175 related articles for article (PubMed ID: 22955431)
1. Association between corticosteroids and infection, sepsis, and infectious death in pediatric acute myeloid leukemia (AML): results from the Canadian infections in AML research group.
Dix D; Cellot S; Price V; Gillmeister B; Ethier MC; Johnston DL; Lewis V; Michon B; Mitchell D; Stobart K; Yanofsky R; Portwine C; Silva M; Bowes L; Zelcer S; Brossard J; Traubici J; Allen U; Beyene J; Sung L
Clin Infect Dis; 2012 Dec; 55(12):1608-14. PubMed ID: 22955431
[TBL] [Abstract][Full Text] [Related]
2. Predictors and outcomes of viridans group streptococcal infections in pediatric acute myeloid leukemia: from the Canadian infections in AML research group.
Lewis V; Yanofsky R; Mitchell D; Dix D; Ethier MC; Gillmeister B; Johnston D; Michon B; Stobart K; Portwine C; Silva M; Cellot S; Price V; Bowes L; Zelcer S; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2014 Feb; 33(2):126-9. PubMed ID: 24064558
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group.
Price V; Portwine C; Zelcer S; Ethier MC; Gillmeister B; Silva M; Schindera C; Yanofsky R; Mitchell D; Johnston DL; Lewis V; Dix D; Cellot S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Pediatr Infect Dis J; 2013 Jun; 32(6):610-3. PubMed ID: 23838731
[TBL] [Abstract][Full Text] [Related]
4. Infections in children with down syndrome and acute myeloid leukemia: a report from the Canadian infections in AML research group.
Tran TH; Mitchell D; Dix D; Cellot S; Ethier MC; Gillmeister B; Hitzler J; Lewis V; Yanofsky R; Johnston DL; Portwine C; Price V; Zelcer S; Silva M; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Infect Agent Cancer; 2013 Dec; 8(1):47. PubMed ID: 24289042
[TBL] [Abstract][Full Text] [Related]
5. Second Bacteremia During Antibiotic Treatment in Children With Acute Myeloid Leukemia: A Report From the Canadian Infections in Acute Myeloid Leukemia Research Group.
Tran TH; Yanofsky R; Johnston DL; Dix D; Gillmeister B; Ethier MC; Portwine C; Price V; Mitchell D; Cellot S; Lewis V; Zelcer S; Silva M; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
J Pediatric Infect Dis Soc; 2014 Sep; 3(3):228-33. PubMed ID: 26625386
[TBL] [Abstract][Full Text] [Related]
6. Cumulative corticosteroid exposure and infection risk after complex pediatric cardiac surgery.
Mastropietro CW; Barrett R; Davalos MC; Zidan M; Valentine KM; Delius RE; Walters HL
Ann Thorac Surg; 2013 Jun; 95(6):2133-9. PubMed ID: 23602063
[TBL] [Abstract][Full Text] [Related]
7. Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia.
Dix D; Aplenc R; Bowes L; Cellot S; Ethier MC; Feusner J; Gillmeister B; Johnston DL; Lewis V; Michon B; Mitchell D; Portwine C; Price V; Silva M; Stobart K; Yanofsky R; Zelcer S; Beyene J; Sung L
Int J Cancer; 2016 Apr; 138(7):1785-91. PubMed ID: 26515793
[TBL] [Abstract][Full Text] [Related]
8. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
9. Invasive fungal infections in paediatric acute myeloid leukaemia.
Johnston DL; Lewis V; Yanofsky R; Gillmeister B; Ethier MC; Mitchell D; Cellot S; Dix D; Portwine C; Price V; Silva M; Zelcer S; Michon B; Bowes L; Stobart K; Brossard J; Beyene J; Sung L
Mycoses; 2013 Jul; 56(4):482-7. PubMed ID: 23437849
[TBL] [Abstract][Full Text] [Related]
10. Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.
Zwitserloot AM; Mavinkurve-Groothuis AM; Galama JM; Verweij PE; Hoogerbrugge PM; Warris A
Scand J Infect Dis; 2012 May; 44(5):355-62. PubMed ID: 22216875
[TBL] [Abstract][Full Text] [Related]
11. Infections in pediatric acute promyelocytic leukemia: from the Canadian infections in acute myeloid leukemia research group.
Cellot S; Johnston D; Dix D; Ethier MC; Gillmeister B; Mitchell D; Yanofsky R; Lewis V; Portwine C; Price V; Zelcer S; Silva M; Bowes L; Michon B; Stobart K; Brossard J; Beyene J; Sung L
BMC Cancer; 2013 Jun; 13():276. PubMed ID: 23735034
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
14. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Lehrnbecher T; Varwig D; Kaiser J; Reinhardt D; Klingebiel T; Creutzig U
Leukemia; 2004 Jan; 18(1):72-7. PubMed ID: 14586478
[TBL] [Abstract][Full Text] [Related]
15. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
[TBL] [Abstract][Full Text] [Related]
17. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
18. Impact on relapse of corticosteroid therapy after allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Imahashi N; Inamoto Y; Seto A; Watanabe K; Nishiwaki S; Yanagisawa M; Shinba M; Yasuda T; Kuwatsuka Y; Atsuta Y; Kodera Y; Miyamura K
Clin Transplant; 2010; 24(6):772-7. PubMed ID: 19925467
[TBL] [Abstract][Full Text] [Related]
19. Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004.
Bochennek K; Hassler A; Perner C; Gilfert J; Schöning S; Klingebiel T; Reinhardt D; Creutzig U; Lehrnbecher T
Blood Cancer J; 2016 Jan; 6(1):e382. PubMed ID: 26771808
[TBL] [Abstract][Full Text] [Related]
20. Favorable outcomes after allogeneic hematopoietic stem cell transplantation in children with high-risk or advanced acute myeloid leukemia.
Koh KN; Park M; Kim BE; Bae KW; Im HJ; Seo JJ
J Pediatr Hematol Oncol; 2011 May; 33(4):281-8. PubMed ID: 21464766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]